No Detail Found!

Mechanism of puerarin-polybutyl cyanoacrylate nanoparticles on apoptosis of brain cells in rats with cardiac arrest/cardiopulmonary resuscitation

Author(s)
X. Zhao Department of Emergency, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine,Hangzhou, 310006, Zhejiang,China
Y.S. Xu Department of Emergency, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine,Hangzhou, 310006, Zhejiang,China
J.Y. Fang Department of Emergency, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine,Hangzhou, 310006, Zhejiang,China
Abstract
Following cardiac resuscitation, cerebral perfusion pressure increases, accompanied by impaired autoregulation of cerebral blood vessels, which subsequently leads to cerebral reperfusion congestion and resultant brain injury. This study aimed to explore the therapeutic mechanism of puerarin (PARI) nanoparticles (NPs) on cardiopulmonary resuscitation after cardiac arrest in rats. PARI-polybutyl cyanoacrylate NPs (PARI-BCA-NPs) were fabricated using PARI as the model drug. While the NPs were physically characterized, the pharmacokinetics and tissue distribution of the intravenously administered drug in rats were studied. Subsequently, a rat cardiac arrest/cardiopulmonary resuscitation (CA/CPR) model was established to evaluate the protective effect of the nanodrug on brain cells. At the same dose, injection of the PARI-BCA-NP solution significantly altered the pharmacokinetic properties, increasing the mean drug retention time, blood concentration, and area under the curve (AUC) by 54% compared to the PARI injection (P<0.05). Relative to the PARI injection group, the AUC of each tissue injected with PARI-BCA-NP solution was increased drastically, and the AUC of the brain tissue injected with the NP solution was 2.72 times that of the brain tissue injected with the PARI parent drug group. Based on the CA/CPR model, rats were grouped (sham operation group, model group, and NP group). The fluorescence intensities of superoxide dismutase (SOD)1 and SOD2 in the NP group at each time point were markedly increased versus the model group (P<0.05), and positive rates of TUNEL and Caspase3/TUNEL were decreased, i.e., the apoptosis rate of brain cells was decreased (P<0.05). PARI-BCA-NPs exhibit excellent pharmacokinetic properties and significantly improve brain injury caused by CA/CPR by reducing oxidative stress and neuronal apoptosis in brain tissue. They demonstrate promising therapeutic potential in animal models, particularly in the intervention of brain injury following CA. Further research will help explore their applicability, especially their feasibility in acute-phase treatment, offering a novel therapeutic strategy.
Publication Details
Page(s) 415-428
Published Journal: Journal of Animal and Plant sciences, Volume: 35, Issue: 2, Year: 2025

Request the full text from PASTIC

Keywords
pharmacokinetics, PARI-BCA-NPs, puerarin, brain cell apoptosis
References
Chen Z.Q.,Zhou Y.,Huang J.W.,Chen F.,Zheng J.,Li H.L.,Li T.,Li L. .2021 .Puerarin pretreatment attenuates cardiomyocyte apoptosis induced by coronary microembolization in rats by activating the PI3K/Akt/GSK-3β signaling pathway. Korean J Physiol Pharmacol, 25(2) : 147-157.
Cheng H.,Yu Z.F.,Zhang H.X.,Jiang P.,Wu Z.G.,Wang Z.B.,Chen L.Q.,Wu L.Q. .2024 .Mxene-bpV plays a neuroprotective role in cerebral ischemiareperfusion injury by activating the Akt and promoting the M2 microglial polarization signaling pathways. J Mater Sci Mater Med, 35(1) : .
Ferraris C.,Cavalli R.,Panciani P.P.,Battaglia P.P. .2020 .Overcoming the blood-brain barrier: successes and challenges in developing nanoparticle-mediated drug delivery systems for the treatment of brain tumours. Int J Nanomedicine, 15 : 2999-3022.
Gvoic S.,Vukmirovic H.,Al-Salami A.,Mooranian M.,Mikov K.,Stankov K. .2021 .Bile acids as novel enhancers of CNS targeting antitumor drugs: a comprehensive review. Pharm Dev Technol, 26(6) : 617-633.
He Y.,Liu B.,Yao P.,Shao Y.,Zhao J.,Wu Z.W.,Zhao W.,Huang T.A.,Christopher B.,Lopez X.,Ma X.,Cao X. .2020 .Adiponectin inhibits cardiac arrest/cardiopulmonary resuscitation-induced apoptosis in brain by increasing autophagy involved in AdipoR1-AMPK signaling. Mol Med Rep, 22(2) : 870-878.
Hoffmann M.,Hersch N.,Merkel R.,Csiszar A.,B. Hoffmann. A. .2019 .Changing the way of entrance: highly efficient transfer of mRNA and siRNA via fusogenic nano-carriers. J Biomed Nanotechnol, 15(1) : 170-183.
Hu W.,Wang H.,Shu Q.,Chen M.,Xie M. .2020 .Green tea polyphenols modulated cerebral SOD expression and endoplasmic reticulum stress in cardiac arrest/cardiopulmonary resuscitation rats. Biomed Res Int, 5080832 : .
Jahansooz F.,Hosseinzade B.E.,Zarmi A.H.,Hadi F.,Hojjati S.M. Massood,Shahpasand K. .2020 .Dopamine-loaded poly (butyl cyanoacrylate) nanoparticles reverse behavioral deficits in Parkinson's animal models. -0026, 11(6) : 387-399.
Lott C.,Truhlář A.,Alfonzo A.,Barelli A.,Nolan J.P.,Paal P.,Perkins G.D.,Thies K.C.,Yeung J.,Zideman D.A.,Soar J. .2021 .European Resuscitation Council guidelines 2021: cardiac arrest in special circumstances. Resuscitation, 02 : 152-219.
Ma Q.,Liu D.,Gong R.,Chen S.,Fang F.,Zhuang Y. .2021 .Mechanically induced vasospasmevaluation of spasmolytic efficacy of 10 pharmaceutical agents using laser speckle contrast imaging. Lasers Surg Med, 53(5) : 684-694.
Matalqah S.M.,Aiedeh K.,Mhaidat N.M.,Alzoubi K.H.,Bustanji Y.,I. Hamad Y. .2020 .Chitosan nanoparticles as a novel drug delivery system: a review article. Curr Drug Targets, 21(15) : 1613-1624.
Matlou G.G. and H.,Abrahamse G.G. and H. .2021 .Hybrid inorganic-organic core-shell nanodrug systems in targeted photodynamic therapy of cancer. Pharmaceutics, 1773(11) : .
Asil Masoudi,S. Masoudi,Ahlawat J.,Barroso G. Guillama,Narayan M. .2020 .Nanomaterial based drug delivery systems for the treatment of neurodegenerative diseases. Biomater Sci, 8(15) : 4109-4128.
Mitchell M.J.,M.M. Billingsley R.M.,Haley M.E.,Wechsler N.A.,Peppas R.,Langer R. .2021 .Engineering precision nanoparticles for drug delivery. Nat Rev Drug Discov, 20(2) : 101-124.
Nguyen N.,Darville A,Vermeulen A .2022 .Pharmacokinetics of long-acting aqueous nano/microsuspensions after intramuscular administration in different animal species and humans: a review. AAPS J, 25(1) : .
Reker D.,Rybakova Y.,Kirtane A.R.,Cao R.,Yang J.W.,Navamajiti N.,Gardner A.,Zhang R.M.,J. L'Heureux R.M.,Erlach E.M.,Smekalova D.,Leboeuf K.,Hess A.,Lopes J.,Rogner S.M.,Tamang K.,Ishida P.,Chamberlain D.,Yun A.,Lytton-Jean C.K.,Soule J.H.,Cheah A.M.,Hayward R.,Langer G.,Traverso G. .2021 .Computationally guided highthroughput design of self-assembling drug nanoparticles. Nat Nanotechnol, 16(6) : 725-733.
Rogers C.,Erkes D.A.,Nardone A.,Aplin A.E.,Fernandes-Alnemri T.,Alnemri E.S. .2019 .Gasdermin pores permeabilize mitochondria to augment caspase-3 activation during apoptosis and inflammasome activation. Nat Commun, 10(1) : .
Sharma G.,Sharma A.R.,Lee S.S.,Bhattacharya M.,Nam J.S.,Chakraborty C. .2019 .Advances in nanocarriers enabled brain targeted drug delivery across blood brain barrier. Int J Pharm, 01 : 360-372.
Singh A.K.,Jiang Y.,Gupta S.,Younus M.,Ramzan M. .2012 .Anti-inflammatory potency of nano-formulated puerarin and curcumin in rats subjected to the lipopolysaccharide-induced inflammation. J Med Food, 16(10) : 899-911.
Song C.,Guo Y.,Wu Y.,Liu Q.,Kong Y.,Wang Y. .2024 .Therapeutic factors and biomaterial-based delivery tools for degenerative intervertebral disc repair. Front Cell Dev Biol, 12 : .
Sønstevold T.,Engedal N.,Torgersen M.L. .2021 .Perturbation of cellular redox homeostasis dictates divergent effects of Polybutyl Cyanoacrylate (PBCA). Nanoparticles on Autophagy. Cells, 3432(12) : .
Subramanian D.A.,Langer R.,Traverso G. .2022 .Mucus interaction to improve gastrointestinal retention and pharmacokinetics of orally administered nano-drug delivery systems. J Nanobiotechnology, 20(1) : .
Unnisa A.,Greig N.H.,Kamal M.A. .2023 .Inhibition of Caspase 3 and Caspase 9 mediated apoptosis: a multimodal therapeutic target in traumatic brain injury. Curr Neuropharmacol, 21(4) : 1001-1012.
Vimalnath K.V.,Rajeswari A.,Patra S.,Kamaleshwaran K.K.,Chakraborty S. .2024 .Multidose formulation and clinical deployment of [Y]Ylabeled hydroxyapatite (HA) microparticles for radiation synovectomy in India- the inherent intricacies. Appl Radiat Isot, 217 : .
Wang J.,M. Zhou J. .2022 .Research progress of Snitrosoglutathione reductase inhibitors in the regulation of cerebral injury after cardiac arrestcardiopulmonary resuscitation. j.cn121430-202100203- 00198, 34(9) : 995-998.
Wang S.A.,Su C.P.,Fan H.Y.,Hou W.H.,Chen Y.C. .2020 .Effects of real-time feedback on cardiopulmonary resuscitation quality on outcomes in adult patients with cardiac arrest: A systematic review and meta-analysis. Resuscitation, 07 : 82-90.
You Q.,Hopf T.,Hintz W.,Rannabauer S.,Voigt N.,B. van Wachem N.,Henrich-Noack P.,Sabel B.A. .2018 .Major effects on blood-retina barrier passage by minor alterations in design of polybutylcyanoacrylate nanoparticles. J Drug Target, 27(3) : 338-346.
Zhang D.,Wang J.,Zhang H.,Zhang Z.,Wang and M. Liu X. .2022 .Drug-loaded PEGPLGA nanoparticles for cancer treatment. Front Pharmacol, 13 : .
Zhang S.,Ou Q.,Xin P.,Yuan Q.,Wang Y.,Wu J .2019 .Polydopamine/puerarin nanoparticleincorporated hybrid hydrogels for enhanced wound healing. Biomater Sci, 7(10) : 4230-4236.
Zhou Y.,Li M.,Song J.,Shi Y.,Qin X.,Gao Z.,Lv Y.,Du G. .2020 .The cardioprotective effects of the new crystal form of puerarin in isoproterenol-induced myocardial ischemia rats based on metabolomics. Sci Rep, 10(1) : .
0

Citations

0

Downloads

20

Views